[HTML][HTML] Tyrosine Kinase Inhibitors in Osteosarcoma: Adapting Treatment Strategies

A Assi, M Farhat, MCR Hachem, Z Zalaquett… - Journal of Bone …, 2023 - Elsevier
Osteosarcoma (OS) is an aggressive primary bone malignancy that metastasizes rapidly.
The standard of care has changed little over the previous four decades, and survival rates …

[HTML][HTML] Trends in primary malignant bone cancer incidence and mortality in the United States, 2000–2017: A population-based study

J Yang, S Lou, T Yao - Journal of Bone Oncology, 2024 - Elsevier
Background Primary malignant bone cancers have extremely low incidence, resulting in
poor evaluation of their epidemiological characteristics. The objective of this study was to …

[HTML][HTML] The relationship of pain catastrophizing in principal caregivers of postoperative children with malignant bone tumors and children's kinesiophobia and pain …

Q Yu, F Fang, L Chen, Q Wang, W Dai - International Journal of Orthopaedic …, 2024 - Elsevier
Objective To examine the phenomenon of pain catastrophizing among the principal
caregivers of postoperative children with malignant bone tumors and explore its impact on …

Unraveling the therapeutic potential of Rutin against osteosarcoma cells: Targeting TNF-α and VEGF signaling pathways

G Gnanamathy, SN Sheela, R Jeevitha, P Elumalai… - 2024 - researchsquare.com
Background Rutin is a flavonoid that is widely distributed in plants and has been identified
as having medicinal qualities as well as potential benefits for treating a range of ailments. In …

Metástase do eixo axial: uma revisão de literatura

ACP Neto, LL do Espírito Santo… - Journal …, 2024 - ojs.latinamericanpublicacoes.com.br
Este estudo objetiva revisar a literatura sobre metástase do eixo axial, focando na
disseminação de células cancerígenas para estruturas ósseas cruciais, como coluna …